Success Metrics

Clinical Success Rate
80.0%

Based on 4 completed trials

Completion Rate
80%(4/5)
Active Trials
3(25%)
Results Posted
0%(0 trials)
Terminated
1(8%)

Phase Distribution

Ph phase_2
5
42%
Ph phase_1
3
25%
Ph not_applicable
4
33%

Phase Distribution

3

Early Stage

5

Mid Stage

0

Late Stage

Phase Distribution12 total trials
Phase 1Safety & dosage
3(25.0%)
Phase 2Efficacy & side effects
5(41.7%)
N/ANon-phased studies
4(33.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

66.7%

4 of 6 finished

Non-Completion Rate

33.3%

2 ended early

Currently Active

3

trials recruiting

Total Trials

12

all time

Status Distribution
Active(3)
Completed(4)
Terminated(2)
Other(3)

Detailed Status

Completed4
unknown3
Recruiting2
Active, not recruiting1
Withdrawn1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
3
Success Rate
80.0%
Most Advanced
Phase 2

Trials by Phase

Phase 13 (25.0%)
Phase 25 (41.7%)
N/A4 (33.3%)

Trials by Status

active_not_recruiting18%
completed433%
withdrawn18%
recruiting217%
terminated18%
unknown325%

Recent Activity

Clinical Trials (12)

Showing 12 of 12 trials
NCT06945042Not Applicable

ONC-LEUK-2406: The Impact of Systematic Financial Navigation in Acute Myeloid Leukemia

Recruiting
NCT03786692Phase 2

Phase II Randomized Trial of Carboplatin+Pemetrexed+Bevacizumab+/- Atezolizumab in Stage IV NSCLC

Active Not Recruiting
NCT06061146Phase 2

Tislelizumab Plus Concurrent Chemoradiation in Older With ESCC

Recruiting
NCT05682495Phase 1

A HR20031 BE Study on Healthy Subjects

Completed
NCT03435484Not Applicable

Using RCT to Increase Completion Rates of the Health Assessment Questionnaire.

Completed
NCT05240521Not Applicable

Efficacy and Safety, Tolerability of GA-AT0119 in IBS-C

Unknown
NCT02079220Phase 2

A Phase II Study of Ziv-aflibercept in Combination With Capecitabine/Oxaliplatin (XELOX) Chemotherapy in the Front-Line Treatment of Patients With Metastatic Colorectal Cancer

Withdrawn
NCT01176799Phase 2

Randomized Study of Doxorubicin and Cyclophosphamide With or Without Intermittent Sunitinib in the First-line Treatment of Locally Advanced or Metastatic Breast Cancer Patients With Measurable Primary Breast Tumor

Unknown
NCT01069081Phase 2

Docetaxel and Cisplatin Chemotherapy With or Without High Dose Proton Pump Inhibitor in Metastatic Breast Cancer

Completed
NCT02358720Phase 1

Single-fraction IMRT Versus External Beam Radiotherapy for Patients With Spine Bone Metastases

Unknown
NCT00756223Phase 1

Phase I Study of BI 831266 in Patients With Advanced Solid Tumours

Completed
NCT01143311Not Applicable

Role of microRNA in the Development of Cutaneous Squamous Cell Carcinoma

Terminated

All 12 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
12